Japan’s Non-Hodgkin Lymphoma Treatment Market Value to Exceed $1 Billion by 2020 is a new market research publication announced by Reportstack. The Non-Hodgkin Lymphoma (NHL) treatment market in the Asia-Pacific (APAC) countries of India, Australia, China and Japan will expand from $1.1 billion in 2013 to $1.7 billion by 2020, with the...
More...
